Intelligence Platform

Patents

Browse 42 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 10758595

Treatment of retinitis pigmentosa using engineered meganucleases

Precision BioSciences, Inc. · Granted Tue Sep 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 27 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10745665

Nucleic acid molecules encoding an engineered antigen receptor and an inhibitory nucleic a

Precision BioSciences, Inc. · Granted Tue Aug 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10662440

Self-limiting viral vectors encoding nucleases

Precision BioSciences, Inc. · Granted Tue May 26 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 21 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10662416

Engineered meganucleases specific for recognition sequences in the hepatitis B virus genom

Precision BioSciences, Inc. · Granted Tue May 26 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 21 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10603363

Treatment of retinitis pigmentosa using engineered meganucleases

Precision BioSciences, Inc. · Granted Tue Mar 31 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10093900

Genetically-modified cells comprising a modified human T cell receptor alpha constant regi

Precision BioSciences, Inc. · Granted Tue Oct 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10093899

Genetically-modified cells comprising a modified human T cell receptor alpha constant regi

Precision BioSciences, Inc. · Granted Tue Oct 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 04 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10041053

Rationally-designed single-chain meganucleases with non-palindromic recognition sequences

Precision BioSciences, Inc. · Granted Tue Aug 07 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 02 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9993501

Genetically-modified cells comprising a modified human T cell receptor alpha constant regi

Precision BioSciences, Inc. · Granted Tue Jun 12 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 07 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9993502

Genetically-modified cells comprising a modified human T cell receptor alpha constant regi

Precision BioSciences, Inc. · Granted Tue Jun 12 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 07 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9969975

Genetically-modified cells comprising a modified human T cell receptor alpha constant regi

Precision BioSciences, Inc. · Granted Tue May 15 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9950011

Genetically-modified cells comprising a modified human T cell receptor alpha constant regi

Precision BioSciences, Inc. · Granted Tue Apr 24 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9950010

Genetically-modified cells comprising a modified human T cell receptor alpha constant regi

Precision BioSciences, Inc. · Granted Tue Apr 24 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9889160

Genetically-modified cells comprising a modified human T cell receptor alpha constant regi

Precision BioSciences, Inc. · Granted Tue Feb 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9889161

Genetically-modified cells comprising a modified human T cell receptor alpha constant regi

Precision BioSciences, Inc. · Granted Tue Feb 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9434931

Rationally-designed single-chain meganucleases with non-palindromic recognition sequences

Precision BioSciences, Inc. · Granted Tue Sep 06 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9340777

Rationally-designed single-chain meganucleases with non-palindromic recognition sequences

Precision BioSciences, Inc. · Granted Tue May 17 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 12 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8445251

Rationally-designed single-chain meganucleases with non-palindromic recognition sequences

Precision BioSciences, Inc. · Granted Tue May 21 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 16 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted